{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T03:29:08Z","timestamp":1770262148243,"version":"3.49.0"},"reference-count":45,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T00:00:00Z","timestamp":1768953600000},"content-version":"vor","delay-in-days":20,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"Haywood Arthritis Foundation"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,1,2]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>Methotrexate (MTX) is the anchor drug for RA but because of its risk\u2013benefit profile it needs careful education to ensure people take it safely. This study explores perspectives of people with RA receiving information provided by rheumatology nurses when starting MTX, focusing on their needs, concerns and whether expectations matched their experiences.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Adults with RA participated in semi-structured qualitative interviews before and after receiving information when starting MTX. Data were analysed using reflexive thematic analysis.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>Nineteen participants attending two rheumatology units in England shared their experiences of receiving information about MTX treatment from a rheumatology nurse. An overarching theme described the desire to receive individualised care tailored to meet specific needs and concerns against experiences of standardised information. Many participants reported not having opportunities to discuss concerns about why they should take MTX. Worries about side-effects and treatment-related harms were frequently unresolved. Recalling practical aspects of treatment and timing of blood tests was often difficult. Knowing when MTX should not be taken and acting on advice to seek medical help if unwell could be hard to understand. Lack of clarity about prescribing and monitoring added complexity and burden.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>These findings provide insights into patient experiences, illustrating unmet information needs when starting MTX to treat RA. People with RA wanted care to address their individual circumstances. A person-centred approach providing tailored information addressing individual needs and concerns offers opportunities to increase patient satisfaction and information recall, leading to improved safety, treatment adherence and patient outcomes.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/rap\/rkaf148","type":"journal-article","created":{"date-parts":[[2026,1,16]],"date-time":"2026-01-16T12:34:52Z","timestamp":1768566892000},"source":"Crossref","is-referenced-by-count":0,"title":["Everyone\u2019s different: a qualitative study of patient perspectives on receiving information about methotrexate from rheumatology nurses"],"prefix":"10.1093","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2003-1325","authenticated-orcid":false,"given":"Sarah J","family":"Logan","sequence":"first","affiliation":[{"name":"Rheumatology, Midlands Partnership University NHS Foundation Trust , Staffordshire,","place":["UK"]},{"name":"Sandwell and West Birmingham NHS Trust , West Midlands,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9958-3909","authenticated-orcid":false,"given":"Samantha L","family":"Hider","sequence":"additional","affiliation":[{"name":"Rheumatology, Midlands Partnership University NHS Foundation Trust , Staffordshire,","place":["UK"]},{"name":"School of Medicine, Keele University , Staffordshire,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2596-8013","authenticated-orcid":false,"given":"Julie A","family":"Green","sequence":"additional","affiliation":[{"name":"Bangor University , Gwynedd,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2202-6266","authenticated-orcid":false,"given":"Sarah J","family":"Ryan","sequence":"additional","affiliation":[{"name":"Rheumatology, Midlands Partnership University NHS Foundation Trust , Staffordshire,","place":["UK"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2026,1,16]]},"reference":[{"key":"2026020408181629900_rkaf148-B1","author":"National Institute for Health and Care Excellence","year":"2025"},{"key":"2026020408181629900_rkaf148-B2","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1136\/annrheumdis-2019-216655","article-title":"EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2019 update","volume":"79","author":"Smolen","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"2026020408181629900_rkaf148-B3","doi-asserted-by":"crossref","first-page":"j3248","DOI":"10.1136\/bmj.j3248","article-title":"Diagnosis and early management of inflammatory arthritis","volume":"358","author":"Ledingham","year":"2017","journal-title":"BMJ"},{"key":"2026020408181629900_rkaf148-B4","author":"National Institute for Health and Care Excellence","year":"2020"},{"key":"2026020408181629900_rkaf148-B5","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1136\/annrheumdis-2014-206807","article-title":"EULAR recommendations for patient education for people with inflammatory arthritis","volume":"74","author":"Zangi","year":"2015","journal-title":"Ann Rheum Dis"},{"key":"2026020408181629900_rkaf148-B6","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1093\/rheumatology\/kew479","article-title":"BSR and BHPR guideline for the prescription and monitoring of non-biologic disease-modifying anti-rheumatic drugs","volume":"56","author":"Ledingham","year":"2017","journal-title":"Rheumatology (Oxford)"},{"key":"2026020408181629900_rkaf148-B7","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1093\/rheumatology\/kez274","article-title":"The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate","volume":"59","author":"Hope","year":"2020","journal-title":"Rheumatology (Oxford)"},{"key":"2026020408181629900_rkaf148-B8","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1093\/rheumatology\/keae055","article-title":"The information required by people with inflammatory arthritis when taking methotrexate: a mixed-methods systematic review","volume":"63","author":"Logan","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026020408181629900_rkaf148-B9","first-page":"180","article-title":"OP0274-HPR patients\u2019 and clinicians\u2019 perspectives and experiences on education and support about methotrexate: findings from a survey to 24 European countries","volume-title":"Ann Rheum Dis","author":"Matos","year":"2023"},{"key":"2026020408181629900_rkaf148-B10","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1136\/annrheumdis-2023-eular.626","article-title":"OP0306-HPR points to consider for patient education provided by nurses on methotrexate use. A European consensus initiative","volume":"82","author":"Marques","year":"2023","journal-title":"Ann Rheum Dis"},{"key":"2026020408181629900_rkaf148-B11","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1093\/rheumatology\/kead593","article-title":"Viewpoint: nurses educating patients about drugs","volume":"63","author":"Robinson","year":"2024","journal-title":"Rheumatology (Oxford)"},{"key":"2026020408181629900_rkaf148-B12","doi-asserted-by":"crossref","first-page":"rkad038","DOI":"10.1093\/rap\/rkad038","article-title":"Adverse events during short- and long-term exposure to low dose weekly methotrexate for rheumatic diseases","volume":"7","author":"Garton","year":"2023","journal-title":"Rheumatol Adv Pract"},{"key":"2026020408181629900_rkaf148-B13","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1093\/rheumatology\/keab917","article-title":"Rates and predictors of methotrexate-related adverse events in patients with early rheumatoid arthritis: results from a nationwide UK study","volume":"61","author":"Sherbini","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026020408181629900_rkaf148-B14","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1080\/14740338.2022.2003328","article-title":"Neuropsychiatric adverse drug reactions associated with low dose methotrexate in rheumatoid arthritis patients","volume":"21","author":"Van Lint","year":"2022","journal-title":"Exp Opin Drug Safety"},{"key":"2026020408181629900_rkaf148-B15","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/art.41451","article-title":"Methotrexate pulmonary toxicity: deep inspiration","volume":"72","author":"Kremer","year":"2020","journal-title":"Arthritis Rheumatol"},{"key":"2026020408181629900_rkaf148-B16","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/rheumatology\/keae223","article-title":"\u2018I couldn\u2019t carry on taking a drug like that\u2019: a qualitative study of patient perspectives on side effects from rheumatology drugs","volume":"64","author":"Berthelsen","year":"2025","journal-title":"Rheumatology (Oxford)"},{"key":"2026020408181629900_rkaf148-B17","doi-asserted-by":"crossref","DOI":"10.7208\/chicago\/9780226458144.001.0001","volume-title":"The structure of scientific revolutions","author":"Kuhn","year":"2012","edition":"4th ed."},{"key":"2026020408181629900_rkaf148-B18","doi-asserted-by":"crossref","DOI":"10.1002\/9781119410867","volume-title":"Qualitative research in health care","author":"Pope","year":"2020","edition":"1st ed"},{"key":"2026020408181629900_rkaf148-B19","author":"Dick B. Convergent interviewing essentials"},{"key":"2026020408181629900_rkaf148-B20","author":"Data Protection Act 2018c","year":"2018"},{"key":"2026020408181629900_rkaf148-B21","author":"Data Protection Act 1998","year":"1998"},{"key":"2026020408181629900_rkaf148-B22","author":"National Institute for Health and Care Research","year":"2024"},{"key":"2026020408181629900_rkaf148-B23","doi-asserted-by":"crossref","first-page":"e80633","DOI":"10.1371\/journal.pone.0080633","article-title":"Understanding patients\u2019 adherence-related beliefs about medicines prescribed for long-term conditions: a meta-analytic review of the necessity-concerns framework","volume":"8","author":"Horne","year":"2013","journal-title":"PLoS One"},{"key":"2026020408181629900_rkaf148-B24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1080\/14780887.2020.1769238","article-title":"One size fits all? What counts as quality practice in (reflexive) thematic analysis?","volume":"18","author":"Braun","year":"2021","journal-title":"Qual Res Psychol"},{"key":"2026020408181629900_rkaf148-B25","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1080\/13645579.2018.1454643","article-title":"Can sample size in qualitative research be determined a priori?","volume":"21","author":"Sim","year":"2018","journal-title":"Int J Soc Res Methodol"},{"key":"2026020408181629900_rkaf148-B26","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1186\/s12913-018-2915-2","article-title":"Application of four dimension criteria to assess rigour of qualitative research in emergency medicine","volume":"18","author":"Forero","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"2026020408181629900_rkaf148-B27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1002\/ev.1427","article-title":"But is it rigorous? Trustworthiness and authenticity in naturalistic evaluation","volume":"1986","author":"Lincoln","year":"1986","journal-title":"New Direct Program Eval"},{"key":"2026020408181629900_rkaf148-B28","author":"Medicines and Health Regulatory Authority","year":"2020"},{"key":"2026020408181629900_rkaf148-B29","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1002\/msc.1804","article-title":"Towards a consensus for nurse education of methotrexate for people with rheumatic and musculoskeletal diseases: a scoping review","volume":"21","author":"Marques","year":"2023","journal-title":"Musculoskeletal Care"},{"key":"2026020408181629900_rkaf148-B30","author":"Institute for Healthcare Advancement","year":"2025"},{"key":"2026020408181629900_rkaf148-B31","first-page":"284","article-title":"Use and effectiveness of the teach-back method in patient education and health outcomes","volume":"36","author":"Yen","year":"2019","journal-title":"Fed Pract"},{"key":"2026020408181629900_rkaf148-B32","author":"NHS Education for Scotland"},{"key":"2026020408181629900_rkaf148-B33","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1016\/j.pec.2020.05.003","article-title":"Effectiveness of multimedia interventions in the provision of patient education on anticoagulation therapy: a review","volume":"103","author":"Sim","year":"2020","journal-title":"Patient Educ Couns"},{"key":"2026020408181629900_rkaf148-B34","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1002\/msc.1361","article-title":"An exploration of the experiences of rheumatology nurses counselling patients on methotrexate therapy","volume":"16","author":"Robinson","year":"2018","journal-title":"Musculoskeletal Care"},{"key":"2026020408181629900_rkaf148-B35","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/msc.1035","article-title":"The educational needs of nurses and allied healthcare professionals caring for people with arthritis: results from a cross-sectional survey","volume":"11","author":"Lillie","year":"2013","journal-title":"Musculoskeletal Care"},{"key":"2026020408181629900_rkaf148-B36","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1136\/annrheumdis-2016-eular.4901","article-title":"SAT0627-HPR educational needs of French rheumatology nurses are not limited to inflammatory arthritis management. Results of the multicentric \u201cCaire\u201d survey","volume":"75","author":"Beauvais","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"2026020408181629900_rkaf148-B37","doi-asserted-by":"crossref","first-page":"e000337","DOI":"10.1136\/rmdopen-2016-000337","article-title":"Educational needs of health professionals working in rheumatology in Europe","volume":"2","author":"Vliet Vlieland","year":"2016","journal-title":"RMD Open"},{"key":"2026020408181629900_rkaf148-B38","volume-title":"A competency framework for rheumatology nurses","author":"Royal College of Nursing","year":"2024","edition":"2nd ed"},{"key":"2026020408181629900_rkaf148-B39","volume-title":"Person-centred practice in nursing and health care: theory and practice","author":"McCormack","year":"2016"},{"key":"2026020408181629900_rkaf148-B40","first-page":"351","article-title":"Inequalities in caregiving strain during the COVID-19 pandemic: conceptual framework and review of the empirical evidence","volume":"8","author":"Schmitz","year":"2024","journal-title":"Int J Care Caring"},{"key":"2026020408181629900_rkaf148-B41","doi-asserted-by":"crossref","first-page":"rkac109","DOI":"10.1093\/rap\/rkac109","article-title":"Digital exclusion as a potential cause of inequalities in access to care: a survey in people with inflammatory rheumatic diseases","volume":"7","author":"Hider","year":"2023","journal-title":"Rheumatol Adv Pract"},{"key":"2026020408181629900_rkaf148-B42","author":"Mistry","year":"2021"},{"key":"2026020408181629900_rkaf148-B43","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s40900-025-00726-y","article-title":"Invisible spectrum: a model for minority community public engagement in cancer research","volume":"11","author":"O\u2019Grady","year":"2025","journal-title":"Res Involv Engagem"},{"key":"2026020408181629900_rkaf148-B44","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/rheumatology\/keac383","article-title":"Health inequalities across patients with early inflammatory arthritis of different ethnicities: what could be the driving factors?","volume":"62","author":"Bergstra","year":"2022","journal-title":"Rheumatology (Oxford)"},{"key":"2026020408181629900_rkaf148-B45","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/rheumatology\/keac266","article-title":"Worse outcomes linked to ethnicity for early inflammatory arthritis in England and Wales: a national cohort study","volume":"62","author":"Adas","year":"2022","journal-title":"Rheumatology (Oxford)"}],"container-title":["Rheumatology Advances in Practice"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/rheumap\/advance-article-pdf\/doi\/10.1093\/rap\/rkaf148\/66492862\/rkaf148.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/10\/1\/rkaf148\/66492862\/rkaf148.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/rheumap\/article-pdf\/10\/1\/rkaf148\/66492862\/rkaf148.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T13:18:30Z","timestamp":1770211110000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/rheumap\/article\/doi\/10.1093\/rap\/rkaf148\/8432923"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"references-count":45,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1,2]]}},"URL":"https:\/\/doi.org\/10.1093\/rap\/rkaf148","relation":{},"ISSN":["2514-1775"],"issn-type":[{"value":"2514-1775","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026]]},"published":{"date-parts":[[2026]]},"article-number":"rkaf148"}}